ZOLOFT is a prescription medicine used to treat depression, panic disorder, obsessive-compulsive disorder (also called OCD) and posttraumatic stressdisorder (also called PTSD) in adults.
ZOLOFT is also used to treat OCD in children (ages 6-12) and adolescents (ages 12-17).
|zoloft 25mg pills|
|zoloft 25mg × 30 pills||price $72.00||per pill 2.40|
|zoloft 25mg × 60 pills||price $88.20||per pill 1.47|
|zoloft 25mg × 90 pills||price $104.40||per pill 1.16|
|zoloft 50mg pills|
|zoloft 50mg × 30 pills||price $75.90||per pill 2.53|
|zoloft 50mg × 60 pills||price $93.00||per pill 1.55|
|zoloft 50mg × 90 pills||price $109.80||per pill 1.22|
|zoloft 50mg × 180 pills||price $158.40||per pill 0.88|
|zoloft 100mg pills|
|zoloft 100mg × 30 pills||price $99.00||per pill 3.30|
|zoloft 100mg × 60 pills||price $120.00||per pill 2.00|
|zoloft 100mg × 90 pills||price $140.40||per pill 1.56|
|zoloft 100mg × 180 pills||price $199.80||per pill 1.11|
ZOLOFT is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, D & C Yellow #10 aluminum lake (in 25 mg tablet), FD & C Blue #1 aluminum lake (in 25 mg tablet), FD & C Red #40 aluminum lake (in 25 mg tablet), FD & C Blue #2 aluminum lake (in 50 mg tablet), hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, synthetic yellow iron oxide (in 100 mg tablet), and titanium dioxide.
ZOLOFT oral concentrate is available in a multidose 60 mL bottle. Each mL of solution contains sertraline hydrochloride equivalent to 20 mg of sertraline. The solution contains the following inactive ingredients: glycerin, alcohol (12%), menthol, butylated hydroxytoluene (BHT). The oral concentrate must be diluted prior to administration.
Women with PCOS are at higher risk of diabetes and cardiovascular and respiratory diseases, and a new study finds they have double the risk of being admitted to hospital.
Predictions for 2015 estimate that, for the first time, the death rates for lung cancer among women in Europe will exceed those for breast cancer.
Healing ability is impaired among people with diabetes - leading, in some cases, to amputations. Now, Penn researchers suggest a mechanism behind this reduced response.